Bullboard - Stock Discussion Forum Minerva Neurosciences Inc NERV

Healthcare Biotechnology

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focused on the development and commercialization of product candidates to treat patients suffering from central nervous system (CNS) diseases. It is engaged in developing roluperidone for the treatment of negative symptoms in patients with schizophrenia and have exclusive rights to develop and commercialize MIN-301... see more

Add To Watchlist

NDAQ:NERV - Post Discussion

Minerva Neurosciences Inc > Regulatory Setback For Minerva Neurosciences' Schizophrenia

View:

Post by whytestocks on Feb 27, 2024 5:15pm

Regulatory Setback For Minerva Neurosciences' Schizophrenia

JUST IN: $NERV Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data | BenzingaMinerva Neurosciences Inc (NASDAQ:NERV) shares are trading lower after the FDA issued a Complete Response Letter (CRL) to the company’s ...NERV - Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data | Benzinga